Hormone-based solutions for weight management, including GLP-1 receptor agonists, are gaining increasing attention. For dietary supplement brands and nutraceutical ingredient manufacturers, these treatments present significant market opportunities. Businesses can benefit from a deeper understanding of their background, applications, current research findings and the compliance landscape that must be navigated to bring them to market successfully.

This webinar explores the key industry trends driving these solutions and delves into the science behind them, examining their impact on energy metabolism and appetite regulation. It also assesses how the nutraceutical industry has responded to their potential. With recent publicity surrounding research from the US and Canada bringing GLP-1 receptor agonists to the fore, our presenters will discuss their safety and explain how expert analysis brings unique insights for brands, helping to build trust and product differentiation.

Agenda:

Introduction
Hormones and weight management: exploring key regulators of satiety and energy metabolism, including GLP-1
Current research developments in the US and Canada: published findings and emerging studies
State of the industry and key trends in weight management (specifically related to GLP-1)
Regulatory updates: analysis of recent warning letters and their implications for brands
Strategic pathways and next steps for brands and manufacturers to successfully penetrate this niche
Q&A

This webinar is aimed at finished product brands and ingredient manufacturers in the nutraceutical industry.